"
Team:Columbia-Cooper-NYC/Safety
From 2012.igem.org
| Home | Team | Official Team Profile | Project | Parts Submitted to the Registry | Modeling | Notebook | Safety | Attributions |
|---|
Contents |
Safety
<body>
Would any of your project ideas raise safety issues in terms of:
researcher safety?
public safety?
environmental safety?
Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,
did you document these issues in the Registry?
how did you manage to handle the safety issue?
How could other teams learn from your experience?
Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes, did you document these issues in the Registry?
Is there a local biosafety group, committee, or review board at your institution?
If yes, what does your local biosafety group think about your project?
If no, which specific biosafety rules or guidelines do you have to consider in your country?
Genspace has an Advisory Board consisting of experts in biosafety, biosecurity, and genetic engineering who hold positions in academia, industry and government. They serve as our Institutional Biosafety Committee. The portions of the project to be carried out at Genspace are strictly BioBrick construction and the construction of plasmids containing metal-binding peptides and other non-pathogenic sequences. This is within the project parameters recommended by our Advisory Board.
<a href="http://genspace.org/page/Advisory%20Board">Advisory Board Members</a>
Cooper Union does not have an Institutional Biosafety Committee, but the project has been reviewed by David Wootton, Ph.D., Director of The Maurice Kanbar Center for Biomedical Engineering and is being supervised by Jody Grapes, Campus-Wide Safety Officer for Cooper Union.
